Novel Combinations of Radiation and Immunotherapy
放射治疗和免疫治疗的新组合
基本信息
- 批准号:8938165
- 负责人:
- 金额:$ 22.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:CellsCessation of lifeCombined Modality TherapyDiseaseDisseminated Malignant NeoplasmGoalsImmuneImmune responseImmunotherapeutic agentImmunotherapyMalignant NeoplasmsMediatingMethodsRadiationRadiation therapySystemic TherapyTherapeuticTimeUnresectableirradiationnovelpalliativeradiation effectsarcomasoft tissuetumortumor microenvironment
项目摘要
Metastatic or unresectable disease is the direct or indirect cause of 90% of all cancer deaths, and curative therapies for the treatment of metastatic cancers are rare. My ultimate goal is to develop methods that that enable us to achieve systemic tumor control after localized irradiation, when localized radiation therapy is indicated. There are no broadly effective systemic therapies for the treatment of metastatic soft tissue sarcomas, but localized palliative radiation therapy is commonly used and provides a therapeutic opportunity if an anti-tumor immune response is induced by immunotherapies administered at the time of the palliative radiation. Combining radiation with immunotherapy is a promising method for treating metastatic malignancies, and we hypothesized that the effects of radiation (RT) on immune cells in the tumor microenvironment will determine the utility of different immunotherapeutic (IT) methods in RT + IT combination therapies. We are identifying immunotherapies that combine effectively with radiation to promote systemic immune-mediated regression of metastatic disease.
转移性或不可切除性疾病是90%的癌症死亡的直接或间接原因,治疗转移性癌症的有效疗法很少。我的最终目标是开发方法,使我们能够在局部放疗后实现全身肿瘤控制,当需要局部放疗时。目前还没有广泛有效的全身治疗转移性软组织肉瘤的方法,但局部姑息性放射治疗是常用的,如果在姑息性放射治疗时使用免疫疗法诱导抗肿瘤免疫反应,则提供了治疗机会。放射联合免疫治疗是治疗转移性恶性肿瘤的一种很有前途的方法,我们假设放射(RT)对肿瘤微环境中免疫细胞的影响将决定不同免疫治疗(IT)方法在RT + IT联合治疗中的效用。我们正在寻找与放疗有效结合的免疫疗法,以促进全身免疫介导的转移性疾病的消退。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jennifer Jones其他文献
Jennifer Jones的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jennifer Jones', 18)}}的其他基金
Discovery of Tumor and Treatment Response Biomarkers
肿瘤和治疗反应生物标志物的发现
- 批准号:
10486871 - 财政年份:
- 资助金额:
$ 22.74万 - 项目类别:
Translational Nanobiology Approaches to SARS-CoV2
SARS-CoV2 的转化纳米生物学方法
- 批准号:
10487071 - 财政年份:
- 资助金额:
$ 22.74万 - 项目类别:
Biophysical Characterization of EVPs and other Macromolecular Nanoparticles
EVP 和其他大分子纳米颗粒的生物物理表征
- 批准号:
10702579 - 财政年份:
- 资助金额:
$ 22.74万 - 项目类别:
Translational Nanobiology Approaches to SARS-CoV2
SARS-CoV2 的转化纳米生物学方法
- 批准号:
10262558 - 财政年份:
- 资助金额:
$ 22.74万 - 项目类别:
Development and use of nanoFACS for analysis and sorting of nanoparticles
NanoFACS 的开发和使用用于纳米粒子的分析和分类
- 批准号:
8938164 - 财政年份:
- 资助金额:
$ 22.74万 - 项目类别:
Discovery of Tumor, Treatment Response, and Systems-based EVP Signatures
肿瘤、治疗反应和基于系统的 EVP 特征的发现
- 批准号:
10702580 - 财政年份:
- 资助金额:
$ 22.74万 - 项目类别: